A new case report was published in Oncoscience’s Volume 12 on March 31, 2025, titled “Cystadenofibroma and contralateral ...

The safety and efficacy of dostarlimab plus chemotherapy in patients with advanced endometrial cancer were confirmed by ...

Evolution in women's cancer diagnostics: from histopathology to molecular testing, personalized treatment for breast, ovarian ...

A comparison of patients with and without BRCA gene mutations receiving prophylactic risk-reduction surgery suggest ...

The Mayo Clinic and Exact Sciences are developing an easy, noninvasive test to detect endometrial cancer in women with ...

001). Fig 1 Distribution of incident patients with endometrial cancer by race/skin color according to age group in Brazil, 2010-2015 (P < .001). Fig 2 Trends in crude endometrial cancer incidence ...

This project aims to develop a multimodal AI framework, including foundational models, to independently and jointly evaluate risk across digital pathology, radiology/radiotherapy, genomics and ...

Results: Age 2 months - 67 years (median 21), sites in cervix (5), ovaries (3), uterus (2). Non-specific symptoms ... One patient with combined high-grade serous ovarian cancer was treated with ...

High-grade serous ovarian cancer (HGSOC) is a highly aggressive and deadly gynecological cancer, with metastasis being a key factor in its poor prognosis. Historically, HGSOC was thought to spread ...

Our framework, validated across eight diverse cancer benchmark datasets from The Cancer Genome Atlas (TCGA), represents a major improvement over current histology-genomic model learning methods. It ...